MacuSight, a pharmaceutical company, has selected etrials’s Trial Intelligence electronic data capture and Site Intelligence IVR services as the central component of its clinical data management process, playing a role in helping MacuSight to glean actionable information from its clinical trial data, thereby enhancing and accelerating decision-making.
According to etrials, MacuSight team has selected the etrials services for not only its functionality, but also its client teams who would be implementing these systems as an integral component in the MacuSight studies’ data management, enrollment and randomization efforts.
Joel Naor, chief medical officer of MacuSight, said: The quality of data and the ability to complete a thorough data analysis are critical success factors for any clinical study. etrials’s Trial Intelligence electronic data capture (EDC) service affords us rapid and accurate data collection, and offers the ability to integrate pertinent IVR data into EDC in real-time.
MacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients’ vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye.
